ACIU Stock Analysis: Buy, Sell, or Hold?
ACIU - AC Immune SA
$2.45
0.00 (0.00%)
▲
5d:
-3.54%
30d:
+8.41%
90d:
-25.76%
BUY
MODERATE Confidence
Analysis Updated: Jul 14, 2026 12:00 AM ET
Earnings: Aug 04, 2026
20d
Get Alerted When ACIU Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ACIU shows positive signals but monitor for confirmation. Market pricing in 16.8% decline. Moderate conviction.
💡 BUY OPPORTUNITY: ACIU shows positive signals but monitor for confirmation. Market pricing in 16.8% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$5.95
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$3.70
33.7% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ACIU is currently trading at $2.45, which is considered fair relative to its 30-day fair value range of $2.28 to $2.54. From a valuation perspective, the stock is trading at a discount (Forward PE: 9.4) compared to its historical average (16.3). Remarkably, the market is currently pricing in an annual earnings decline of 16.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ACIU is in a downtrend. Immediate support is located at $2.15, while resistance sits at $2.63.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.51 (+247.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ACIU is in a downtrend. Immediate support is located at $2.15, while resistance sits at $2.63.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.51 (+247.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.28 -
$2.54
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.4%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 247.3% below Wall St target ($8.51)
Trading Range Analysis
30-Day Trading Range
$2.28 -
$2.54
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$2.15
Resistance Level
$2.63
Current Trend
Downtrend
Technical data as of
Jul 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.40
Wall Street Target
$8.51
(+247.3%)
Revenue Growth (YoY)
13.0%
Valuation Discount vs History
-16.8% cheaper
PE vs Historical
9.4 vs 16.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-16.8%
(market-implied from PE analysis)
1-Year Target
$2.21
(-10%)
2-Year Target
$1.98
(-19%)
3-Year Target
$1.79
(-27%)
3-Yr Target (if PE normalizes)
(PE: 9→16)
$3.10
(+26%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 9.4 to 16.3
Stabilization Target:
$4.25
(+73.4%)
PE Expansion Potential:
+73.4%
Share & Embed Analysis
Last updated: July 14, 2026 2:12 PM ET
Data refreshes hourly during market hours. Next update: 3:12 PM
Data refreshes hourly during market hours. Next update: 3:12 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACIU showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$441 | 58 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 59 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$258 | 64 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 61 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 61 BUY |
